Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux

Journal of Pediatric Gastroenterology and Nutrition

Volumn 46, Issue 3, 2008, Pages 352-354

  Khoshoo, Vikram ^a   Dhume, Pooja ^b  

^a West Jefferson Medical Center   (United States)

^b St Louis Children's Hospital   (United States)

Author keywords

Gastroesophageal reflux; Lansoprazole; Revised Infant Gastroesophageal Reflux Questionnaire

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ENZYME INHIBITOR; LANSOPRAZOLE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INFANT; MALE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; MALE; TREATMENT OUTCOME;

EID: 43049168712     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31815667d7     Document Type: Article

References (0)